Clinicopathologic Conference, Antiphospholipid Syndrome due to SLE with Hypocomplimentemia
NEJM 389: 2277-2285, Case 38-2023, 2023
Clinicopathological Conference, Systemic Lupus Erythematosus with Antiphospholipid Syndrome
NEJM 386:1560-1570, Case 12-2022, 2022
Antiplatelet and Anticoagulant Agents for Secondary Prevention of Thromboembolic Events in People with Antiphospholipid Syndrome
Stroke 49:e41-e42, Bala, M.M.,et al, 2018
Diagnosis and Management of the Antiphospholipid Syndrome
NEJM 378:2010-2021, Garcia, D. & Erkan, D., 2018
A Young Woman with Progressive Headache and Pancytopenia
Neurol 88:e132-e136, Conrad, E.C.,et al, 2017
Value of MRI of the Brain in Patients with Systemic Lupus Erythematosus and Neurologic Disturbance
Neuroradiol 46:15-21, Jennings, J.E.,et al, 2014
Diagnosis and Management of the Antiphospholipid Syndrome
BMJ 340:1125-1132, Cohen,D., et al, 2010
Reversible Posterior Leukoencephalopathy Syndrome in Catastrophic Antiphospholipid Syndrome
Cerebrovasc Dis 24:141-143, Renard,D.,et al, 2007
A Blinding Combination
Lancet 360:1220, Matthews,B.N.,et al, 2002
Chorea and Antiphospholipid Antibodies: Treatment with Methotrexate
Neurol 56:137-138, Paus,S.,et al, 2001
A Language Barrier, Abdominal Pain, and Double Vision
Lancet 357:2022, Basnyat,B.,et al, 2001
Reversible Dementia and Chorea in a Young Woman with the Lupus Anticoagulant
Neurol 46:1599-1603, Van Horn,G.,et al, 1996
The Management of Thrombosis in the Antiphospholipid-Antibody Syndrome
NEJM 332:993-997, 10251995., Khamashta,M.A.,et al, 1995
Antiphospholipid Antibody Syndrome
JAMA 268:1451-1453, Lockshin,M.D., 1992